Je veux savoir à propos de…

7892

Federal Register / Vol. 86, No. 20 / Tuesday, February 2, 2021 / Notices
ATTACHMENT 1GENERAL TARGET SCHEDULE FOR PROCESSING AND RESOLVING REQUESTS FOR ACCESS TO SENSITIVE
UNCLASSIFIED NON-SAFEGUARDS INFORMATION AND SAFEGUARDS INFORMATION IN THIS PROCEEDINGContinued Day
Event/Activity
>A + 60

Decision on contention admission.

FR Doc. 202101310 Filed 2121; 8:45 am BILLING CODE 759001P

NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Call for Nominations U.S. Nuclear Regulatory Commission.
ACTION: Call for nominations.
AGENCY:

SUMMARY: The U.S. Nuclear Regulatory Commission NRC is soliciting nominations for the Health Care Administrator position on the Advisory Committee of the Medical Uses of Isotopes ACMUI. Health Care Administrator nominees should have professional experience with and/or extensive knowledge about health care administration. Involvement and leadership in professional societies or organizations is preferred.
DATES: Nominations are due on or before April 5, 2021.
ADDRESSES: Nomination Process:
Submit an electronic copy of resume or curriculum vitae, along with a cover letter, to Ms. Kellee Jamerson, Kellee.Jamerson@nrc.gov. The cover letter should describe the nominees current involvement with health care administration and express the nominees interest in the position.
Please ensure that the resume or curriculum vitae includes the following information, if applicable: Education;
certifications; professional association and committee membership activities;
and number of years, timeframe, and type of setting for health care administration.

Ms.
Kellee Jamerson, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards;
301 4157408; Kellee.Jamerson@
nrc.gov.

FOR FURTHER INFORMATION CONTACT:

The ACMUI Health Care Administrator representative provides advice to the NRC staff on a broad perspective of various interests, to include, patients interests, physicians interests, and hospitals interests, as they apply to radiation safely, the treatment of patients, and NRCs medical-use policy.

jbell on DSKJLSW7X2PROD with NOTICES

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

20:09 Feb 01, 2021

Jkt 253001

This individual is appointed based on his or her educational background, certifications, professional experience, involvement and/or leadership in professional societies or organizations, and other information obtained in letters or during the selection process.
The ACMUI advises the NRC on policy and technical issues that arise in the regulation of the medical use of byproduct material. Responsibilities include providing comments on changes to the NRC regulations and guidance;
evaluating certain non-routine uses of byproduct material; providing technical assistance in licensing, inspection, and enforcement cases; and bringing key issues to the attention of the NRC staff, for appropriate action.
ACMUI members are selected based on their educational background, certifications, work experience, involvement and/or leadership in professional society activities, and other information obtained from recommendation letters or during the selection process. Nominees should have the demonstrated ability to establish effective work relationships with peers and implement successful approaches to problem solving and conflict resolution. ACMUI members currently serve a four-year term and may be considered for reappointment to a second term. The current ACMUI
membership is comprised of the following professionals: a Nuclear medicine physician; b nuclear cardiologist; c nuclear medicine physicist; d therapy medical physicist;
e radiation safety officer; f nuclear pharmacist; g two radiation oncologists; h patients rights advocate; i Food and Drug Administration representative; j Agreement State representative; k healthcare administrator; and l diagnostic radiologist. For additional information about membership on the ACMUI, visit the ACMUI Membership web page, https www.nrc.gov/aboutnrc/regulatory/advisory/acmui/
membership.html.
Nominees must be U.S. citizens and be able to devote up to 160 hours per year to ACMUI business. Members are expected to attend semi-annual meetings in Rockville, Maryland and to participate in teleconferences or virtual meetings, as needed. Members who are
PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

not Federal employees are compensated for their service. In addition, members are reimbursed for travel including per diem in lieu of subsistence and are reimbursed secretarial and correspondence expenses. Full-time Federal employees are reimbursed for travel expenses only.
Security Background Check: The selected nominee will undergo a thorough security background check.
Security paperwork may take the nominee several weeks to complete.
Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest.
Dated at Rockville, Maryland this 27th day of January, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell, Federal Advisory Committee Management Officer.
FR Doc. 202102112 Filed 2121; 8:45 am BILLING CODE 759001P

SECURITIES AND EXCHANGE
COMMISSION
Investment Company Act Release No.
34182; File No. 81215099

Hamilton Lane Private Assets Fund, et al.
January 28, 2021.

Securities and Exchange Commission Commission.
ACTION: Notice.
AGENCY:

Notice of application for an order under sections 17d and 57i of the Investment Company Act of 1940 the Act and rule 17d1 under the Act to permit certain joint transactions otherwise prohibited by sections 17d and 57a4 of the Act and rule 17d1
under the Act. Applicants request an order to permit a closed-end management investment company to coinvest in portfolio companies with affiliated investment funds.
APPLICANTS: Hamilton Lane Private Assets Fund the Fund, Hamilton Lane Advisors, L.L.C. Hamilton Lane, 2020 Tactical Market Fund LP, Edgewood Partners LP, Fifth Stockholm CI SPV L.P., Finance Street AIV Splitter L.P., Florida Growth Fund II LLC, Green Core Fund, L.P., Hamilton Lane Co-

E:FRFM02FEN1.SGM

02FEN1